3,5-dichloro-2'-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g

4-Bromo-4'-pentyl-1,1'-biphenyl, 95.0%, 25g

Tetrahydrofuran-2-carboxylic acid, 95.0%, 25g

4-Bromo-2-methylbenzaldehyde, 98.0%, 25g

Sodium 2-benzamidoacetate, 95+%, 500g

[5-(trifluoromethoxy)-2-pyridyl]methanol, 98%, 100mg

4-(1H-Pyrazol-1-yl)piperidine, 95.0%, 1g

Oxion Inverso OX.2053-PLPH-ICSI with LWD Plan phase 10x/20x/40x objectives, ICSI equipment and XY cross table

3-(4-(Trifluoromethyl)phenyl)propan-1-amine, 95+%, 500mg

3-ISOPROPYLPYRAZIN-2-OL, 95.0%, 1g

5-Fluoro-4-methyl-1H-indazole, 95.0%, 250mg

(S)-2-Methyl-1-phenylpropan-1-amine, 95.0%, 250mg

N-(2-HYDROXY-2-METHYLPROPYL)-4-METHYLBENZENESULFONAMIDE, 95.0%, 100mg